Kinsale Capital Group, Inc.

  • Market Cap: Small Cap
  • Industry: Insurance
  • ISIN: US49714P1084
USD
361.26
-13.15 (-3.51%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Kinsale Capital Group, Inc. stock-summary
stock-summary
Kinsale Capital Group, Inc.
Insurance
Kinsale Capital Group, Inc. is a specialty insurance company. The Company focuses on the excess and surplus lines (E&S) market in the United States. The Company operates through the Excess and Surplus Lines Insurance segment. The Company markets and sells these insurance products in approximately 50 states and the District of Columbia through a network of independent insurance brokers. The Company's commercial lines offerings include construction, small business, excess casualty, general casualty, energy, professional liability, life sciences, product liability, allied health, healthcare, commercial property, management liability, environmental, inland marine, commercial insurance and public entity. The Company writes an array of coverages with a focus on smaller commercial buyers. The Company also writes a small amount of homeowners insurance in the personal lines market. The Company's subsidiaries include Kinsale Management, Inc. and Kinsale Insurance Company.
Company Coordinates stock-summary
Company Details
2035 MAYWILL STREET, SUITE 100 , RICHMOND VA : 23230
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 133 Schemes (54.55%)

Foreign Institutions

Held by 186 Foreign Institutions (12.28%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Robert Lippincott
Independent Chairman of the Board
Mr. Michael Kehoe
President, Chief Executive Officer, Director
Ms. Teresa Chia
Director
Mr. Robert Hatcher
Director
Mr. Steven Bensinger
Independent Director
Ms. Anne Kronenberg
Independent Director
Mr. James Ritchie
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
134 Million
stock-summary
Industry

Insurance

stock-summary
Market cap

USD 10,528 Million (Small Cap)

stock-summary
P/E

27.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

7.01%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

25.93%

stock-summary
Price to Book

6.11